275 related articles for article (PubMed ID: 20691874)
21. Mouse induced pluripotent stem cells.
Geoghegan E; Byrnes L
Int J Dev Biol; 2008; 52(8):1015-22. PubMed ID: 18956334
[TBL] [Abstract][Full Text] [Related]
22. Two-step generation of induced pluripotent stem cells from mouse fibroblasts using Id3 and Oct4.
Moon JH; Heo JS; Kwon S; Kim J; Hwang J; Kang PJ; Kim A; Kim HO; Whang KY; Yoon BS; You S
J Mol Cell Biol; 2012 Feb; 4(1):59-62. PubMed ID: 22131360
[No Abstract] [Full Text] [Related]
23. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2.
Huangfu D; Osafune K; Maehr R; Guo W; Eijkelenboom A; Chen S; Muhlestein W; Melton DA
Nat Biotechnol; 2008 Nov; 26(11):1269-75. PubMed ID: 18849973
[TBL] [Abstract][Full Text] [Related]
24. Sox2 transduction enhances cardiovascular repair capacity of blood-derived mesoangioblasts.
Koyanagi M; Iwasaki M; Rupp S; Tedesco FS; Yoon CH; Boeckel JN; Trauth J; Schütz C; Ohtani K; Goetz R; Iekushi K; Bushoven P; Momma S; Mummery C; Passier R; Henschler R; Akintuerk H; Schranz D; Urbich C; Galvez BG; Cossu G; Zeiher AM; Dimmeler S
Circ Res; 2010 Apr; 106(7):1290-302. PubMed ID: 20185800
[TBL] [Abstract][Full Text] [Related]
25. Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice.
Kaichi S; Hasegawa K; Takaya T; Yokoo N; Mima T; Kawamura T; Morimoto T; Ono K; Baba S; Doi H; Yamanaka S; Nakahata T; Heike T
Cardiovasc Res; 2010 Nov; 88(2):314-23. PubMed ID: 20547733
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer.
Hoshino H; Nagano H; Haraguchi N; Nishikawa S; Tomokuni A; Kano Y; Fukusumi T; Saito T; Ozaki M; Sakai D; Satoh T; Eguchi H; Sekimoto M; Doki Y; Mori M; Ishii H
Int J Oncol; 2012 May; 40(5):1423-30. PubMed ID: 22293932
[TBL] [Abstract][Full Text] [Related]
27. Oct4-enhanced green fluorescent protein transgenic pigs: a new large animal model for reprogramming studies.
Nowak-Imialek M; Kues WA; Petersen B; Lucas-Hahn A; Herrmann D; Haridoss S; Oropeza M; Lemme E; Schöler HR; Carnwath JW; Niemann H
Stem Cells Dev; 2011 Sep; 20(9):1563-75. PubMed ID: 21126163
[TBL] [Abstract][Full Text] [Related]
28. Generation of p53-deficient induced pluripotent stem cells from mouse embryo fibroblasts.
Alexandrova EM; Moll UM
Methods Mol Biol; 2013; 962():157-64. PubMed ID: 23150445
[TBL] [Abstract][Full Text] [Related]
29. An improved method for generating and identifying human induced pluripotent stem cells.
Mali P; Ye Z; Chou BK; Yen J; Cheng L
Methods Mol Biol; 2010; 636():191-205. PubMed ID: 20336524
[TBL] [Abstract][Full Text] [Related]
30. Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusion.
Hasegawa K; Zhang P; Wei Z; Pomeroy JE; Lu W; Pera MF
Stem Cells; 2010 Aug; 28(8):1338-48. PubMed ID: 20572011
[TBL] [Abstract][Full Text] [Related]
31. Pluripotent reprogramming of fibroblasts by lentiviral mediated insertion of SOX2, C-MYC, and TCL-1A.
Picanço-Castro V; Russo-Carbolante E; Reis LC; Fraga AM; de Magalhães DA; Orellana MD; Panepucci RA; Pereira LV; Covas DT
Stem Cells Dev; 2011 Jan; 20(1):169-80. PubMed ID: 20504151
[TBL] [Abstract][Full Text] [Related]
32. Oct4-induced pluripotency in adult neural stem cells.
Kim JB; Sebastiano V; Wu G; Araúzo-Bravo MJ; Sasse P; Gentile L; Ko K; Ruau D; Ehrich M; van den Boom D; Meyer J; Hübner K; Bernemann C; Ortmeier C; Zenke M; Fleischmann BK; Zaehres H; Schöler HR
Cell; 2009 Feb; 136(3):411-9. PubMed ID: 19203577
[TBL] [Abstract][Full Text] [Related]
33. Simple and efficient method for generation of induced pluripotent stem cells using piggyBac transposition of doxycycline-inducible factors and an EOS reporter system.
Tsukiyama T; Asano R; Kawaguchi T; Kim N; Yamada M; Minami N; Ohinata Y; Imai H
Genes Cells; 2011 Jul; 16(7):815-25. PubMed ID: 21658168
[TBL] [Abstract][Full Text] [Related]
34. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression.
Eminli S; Utikal J; Arnold K; Jaenisch R; Hochedlinger K
Stem Cells; 2008 Oct; 26(10):2467-74. PubMed ID: 18635867
[TBL] [Abstract][Full Text] [Related]
35. Generation of human-induced pluripotent stem cells.
Park IH; Lerou PH; Zhao R; Huo H; Daley GQ
Nat Protoc; 2008; 3(7):1180-6. PubMed ID: 18600223
[TBL] [Abstract][Full Text] [Related]
36. [Induced pluripotent stem cells].
Shevchenko AI; Medvedev SP; Mazurok NA; Zakiian SM
Genetika; 2009 Feb; 45(2):160-8. PubMed ID: 19334609
[TBL] [Abstract][Full Text] [Related]
37. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
[TBL] [Abstract][Full Text] [Related]
38. Induced pluripotent stem cells expressing elevated levels of sox-2, oct-4, and klf-4 are severely reduced in their differentiation from mesodermal to hematopoietic progenitor cells.
Seiler K; Soroush Noghabi M; Karjalainen K; Hummel M; Melchers F; Tsuneto M
Stem Cells Dev; 2011 Jul; 20(7):1131-42. PubMed ID: 21348597
[TBL] [Abstract][Full Text] [Related]
39. Induction of pluripotency: from mouse to human.
Zaehres H; Schöler HR
Cell; 2007 Nov; 131(5):834-5. PubMed ID: 18045526
[TBL] [Abstract][Full Text] [Related]
40. NANOG is a key factor for induction of pluripotency in bovine adult fibroblasts.
Sumer H; Liu J; Malaver-Ortega LF; Lim ML; Khodadadi K; Verma PJ
J Anim Sci; 2011 Sep; 89(9):2708-16. PubMed ID: 21478453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
